Bo Liu

机构：Sun Yat-sen University, Chinese Academy of Sciences, Shanghai Institute of Materia Medica, Institute for Advanced Study, Third Affiliated Hospital of Sun Yat-sen University · ORCID：0000-0003-0342-8144

发表论文 67 篇 · 总被引 2002 次 · h-index 24

代表论文

• The global landscape of approved antibody therapies (2022 · Antibody Therapeutics · 被引 176)
• Design, Synthesis, and Pharmacological Evaluation of Biaryl-Containing PD-1/PD-L1 Interaction Inhibitors Bearing a Unique Difluoromethyleneoxy Linkage (2021 · Journal of Medicinal Chemistry · 被引 59)
• A Traceless Site‐Specific Conjugation on Native Antibodies Enables Efficient One‐Step Payload Assembly (2022 · Angewandte Chemie International Edition · 被引 49)
• IKZF3 deficiency potentiates chimeric antigen receptor T cells targeting solid tumors (2021 · Cancer Letters · 被引 46)
• Influence mechanism of components and characteristics on structural and oxidative stability of emulsion gel (2024 · Food Hydrocolloids · 被引 42)
• Multicomponent coupling and macrocyclization enabled by Rh(III)-catalyzed dual C–H activation: Macrocyclic oxime inhibitor of influenza H1N1 (2022 · Chem · 被引 31)